351 related articles for article (PubMed ID: 20200976)
1. Progressive ankylosis protein (ANK) in osteoblasts and osteoclasts controls bone formation and bone remodeling.
Kim HJ; Minashima T; McCarthy EF; Winkles JA; Kirsch T
J Bone Miner Res; 2010 Aug; 25(8):1771-83. PubMed ID: 20200976
[TBL] [Abstract][Full Text] [Related]
2. Progressive ankylosis gene (ank) regulates osteoblast differentiation.
Kirsch T; Kim HJ; Winkles JA
Cells Tissues Organs; 2009; 189(1-4):158-62. PubMed ID: 18728347
[TBL] [Abstract][Full Text] [Related]
3. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption.
Mizoguchi F; Izu Y; Hayata T; Hemmi H; Nakashima K; Nakamura T; Kato S; Miyasaka N; Ezura Y; Noda M
J Cell Biochem; 2010 Apr; 109(5):866-75. PubMed ID: 20039311
[TBL] [Abstract][Full Text] [Related]
4. A Phe377del mutation in ANK leads to impaired osteoblastogenesis and osteoclastogenesis in a mouse model for craniometaphyseal dysplasia (CMD).
Chen IP; Wang L; Jiang X; Aguila HL; Reichenberger EJ
Hum Mol Genet; 2011 Mar; 20(5):948-61. PubMed ID: 21149338
[TBL] [Abstract][Full Text] [Related]
5. Coenzyme q10 regulates osteoclast and osteoblast differentiation.
Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK
J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186
[TBL] [Abstract][Full Text] [Related]
6. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
[TBL] [Abstract][Full Text] [Related]
7. Zinc deficiency decreases osteoblasts and osteoclasts associated with the reduced expression of Runx2 and RANK.
Hie M; Iitsuka N; Otsuka T; Nakanishi A; Tsukamoto I
Bone; 2011 Dec; 49(6):1152-9. PubMed ID: 21893222
[TBL] [Abstract][Full Text] [Related]
8. Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts.
Kim JL; Kang SW; Kang MK; Gong JH; Lee ES; Han SJ; Kang YH
J Cell Biochem; 2012 Jan; 113(1):247-59. PubMed ID: 21898547
[TBL] [Abstract][Full Text] [Related]
9. Vanin-1 pantetheinase drives increased chondrogenic potential of mesenchymal precursors in ank/ank mice.
Johnson KA; Yao W; Lane NE; Naquet P; Terkeltaub RA
Am J Pathol; 2008 Feb; 172(2):440-53. PubMed ID: 18187567
[TBL] [Abstract][Full Text] [Related]
10. Osteoblast extracellular Ca2+ -sensing receptor regulates bone development, mineralization, and turnover.
Dvorak-Ewell MM; Chen TH; Liang N; Garvey C; Liu B; Tu C; Chang W; Bikle DD; Shoback DM
J Bone Miner Res; 2011 Dec; 26(12):2935-47. PubMed ID: 21956637
[TBL] [Abstract][Full Text] [Related]
11. Administration of zinc inhibits osteoclastogenesis through the suppression of RANK expression in bone.
Hie M; Tsukamoto I
Eur J Pharmacol; 2011 Oct; 668(1-2):140-6. PubMed ID: 21806983
[TBL] [Abstract][Full Text] [Related]
12. Exogenous Runx2 expression enhances in vitro osteoblastic differentiation and mineralization in primary bone marrow stromal cells.
Byers BA; García AJ
Tissue Eng; 2004; 10(11-12):1623-32. PubMed ID: 15684671
[TBL] [Abstract][Full Text] [Related]
13. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
14. Macrolactin A protects against LPS-induced bone loss by regulation of bone remodeling.
Sapkota M; Gao M; Li L; Yang M; Shrestha SK; Choi H; Soh Y
Eur J Pharmacol; 2020 Sep; 883():173305. PubMed ID: 32673673
[TBL] [Abstract][Full Text] [Related]
15. Zinc deficiency suppresses matrix mineralization and retards osteogenesis transiently with catch-up possibly through Runx 2 modulation.
Kwun IS; Cho YE; Lomeda RA; Shin HI; Choi JY; Kang YH; Beattie JH
Bone; 2010 Mar; 46(3):732-41. PubMed ID: 19913120
[TBL] [Abstract][Full Text] [Related]
16. Osteoblast protects osteoclast devoid of sodium-dependent vitamin C transporters from oxidative cytotoxicity of ascorbic acid.
Takarada T; Hinoi E; Kambe Y; Sahara K; Kurokawa S; Takahata Y; Yoneda Y
Eur J Pharmacol; 2007 Dec; 575(1-3):1-11. PubMed ID: 17698058
[TBL] [Abstract][Full Text] [Related]
17. Nell-1, a key functional mediator of Runx2, partially rescues calvarial defects in Runx2(+/-) mice.
Zhang X; Ting K; Bessette CM; Culiat CT; Sung SJ; Lee H; Chen F; Shen J; Wang JJ; Kuroda S; Soo C
J Bone Miner Res; 2011 Apr; 26(4):777-91. PubMed ID: 20939017
[TBL] [Abstract][Full Text] [Related]
18. The role of the progressive ankylosis protein (ANK) in adipogenic/osteogenic fate decision of precursor cells.
Minashima T; Quirno M; Lee YJ; Kirsch T
Bone; 2017 May; 98():38-46. PubMed ID: 28286238
[TBL] [Abstract][Full Text] [Related]
19. The Transcriptional Modulator Interferon-Related Developmental Regulator 1 in Osteoblasts Suppresses Bone Formation and Promotes Bone Resorption.
Iezaki T; Onishi Y; Ozaki K; Fukasawa K; Takahata Y; Nakamura Y; Fujikawa K; Takarada T; Yoneda Y; Yamashita Y; Shioi G; Hinoi E
J Bone Miner Res; 2016 Mar; 31(3):573-84. PubMed ID: 26391411
[TBL] [Abstract][Full Text] [Related]
20. P5L mutation in Ank results in an increase in extracellular inorganic pyrophosphate during proliferation and nonmineralizing hypertrophy in stably transduced ATDC5 cells.
Zaka R; Stokes D; Dion AS; Kusnierz A; Han F; Williams CJ
Arthritis Res Ther; 2006; 8(6):R164. PubMed ID: 17067391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
